Author: crjfinlayson

December 22, 2021 All amounts expressed in Canadian dollars unless otherwise noted TORONTO, Canada and RIONEGRO, Colombia (December 22, 2021) – PharmaCielo Ltd. (“PharmaCielo”or the “Company”) (TSXV: PCLO, OTCQX: PCLOF), the Canadian parent of Colombia’s premier cultivator and producer of medicinal-grade cannabis extracts, PharmaCielo Colombia

November 29, 2021 Received confirmation of Colombian GMP Certification for Phytotherapeutics manufactured with proprietary PharmaCielo extracts and cultivars. Currently working toward EU-GMP certification, expected to be achieved in the first half of 2022. Executing on opportunities to streamline the business – In the three months

September 14, 2021 PharmaCielo Receives Confirmation of Colombian Phytotherapeutics GMP Certification GMP[i] certification has been confirmed by INVIMA. The certification covers Phytotherapeutics manufactured with PharmaCielo´s extracts and proprietary cultivars. PharmaCielo’s Processing and Extraction Centre – the largest in Colombia and one of the largest globally – has

September 1, 2021 DeGabrielle was an early entrepreneur and executive in the U.S. cannabis industry; he founded and owns Los Sueños Farms LLC, the largest outdoor grow in North America, which he recently agreed to sell to Curaleaf, Inc. Nicholas is an experienced finance professional

August 20, 2021 Bill Petron, the Company's Chairman and a global operations and cannabis veteran, has been appointed Chief Executive Officer of PharmaCielo. Bill Petron is a highly respected entrepreneur with a diverse background in manufacturing, logistics and medical cannabis. He founded companies as MSI

Canadian-Colombian medical cannabis extracts producer PharmaCielo Ltd (TSXV:PCLO) (OTCQX:PCLOF) added another Brazilian-based customer to its roster. The company announced this week that it signed a sales agreement and already completed an initial commercial sale of CBD Isolate to an undisclosed pharmaceutical company To continue reading,

July 28, 2021 Find the latest interview that our CEO, Henning von Koss had with a Canadian cannabis magazine, Mugglehead, where he provided insights and context about the new regulations introduced by the Colombian President as well as how PharmaCielo is going to take advantage

July 1, 2021 Our CEO, Henning von Koss, recently interviewed with Canada’s Business of Cannabis where he discussed the company’s increased focus on becoming a product developing partner to clients through an early integration into their supply chains with higher-value and innovative extracts and APIs.

June 17, 2021 Our CEO, Henning von Koss, talked recently with MMJ Daily - an international media platform for legal and professional growers, researchers and suppliers in the global medical cannabis industry. During the interview, Henning outlined PharmaCielo’s long-term strategic approach, setting the standard for

June 11, 2021 Our CEO, Henning von Koss was recently interviewed by Rena Sherbill the Cannabis editor of Seeking Alpha, a leading investment intelligence and news media outlet. In this interview, Mr. Von Koss talks about PharmaCielo’s unique business strategy and market position as a